MedDream PACS Premium 7.3.6.870 config.php Status cross site scripting
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 5.2 | $0-$5k | 0.00 |
Summary
A vulnerability was found in MedDream PACS Premium 7.3.6.870. It has been rated as problematic. This vulnerability affects unknown code of the file config.php. This manipulation of the argument Status causes cross site scripting. This vulnerability is handled as CVE-2025-58087. The attack can be initiated remotely. There is not any exploit available.
Details
A vulnerability was found in MedDream PACS Premium 7.3.6.870. It has been declared as problematic. Affected by this vulnerability is an unknown function of the file config.php. The manipulation of the argument status with an unknown input leads to a cross site scripting vulnerability. The CWE definition for the vulnerability is CWE-79. The product does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is used as a web page that is served to other users. As an impact it is known to affect integrity. The summary by CVE is:
Multiple reflected cross-site scripting (xss) vulnerabilities exist in the config.php functionality of MedDream PACS Premium 7.3.6.870. Specially crafted malicious URLs can lead to arbitrary javascript code execution. An attacker can provide a crafted URL to trigger these vulnerabilities.This vulnerability affects the status parameter.
This vulnerability is known as CVE-2025-58087. The exploitation appears to be easy. The attack can be launched remotely. The exploitation doesn't need any form of authentication. It demands that the victim is doing some kind of user interaction. Technical details of the vulnerability are known, but there is no available exploit. The attack technique deployed by this issue is T1059.007 according to MITRE ATT&CK.
By approaching the search of inurl:config.php it is possible to find vulnerable targets with Google Hacking.
There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.
The vulnerability is also documented in the vulnerability database at EUVD (EUVD-2026-3418). Statistical analysis made it clear that VulDB provides the best quality for vulnerability data.
Product
Vendor
Name
Version
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔒VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 5.2VulDB Meta Temp Score: 5.2
VulDB Base Score: 4.3
VulDB Temp Score: 4.3
VulDB Vector: 🔒
VulDB Reliability: 🔍
CNA Base Score: 6.1
CNA Vector: 🔒
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔒
VulDB Temp Score: 🔒
VulDB Reliability: 🔍
Exploiting
Class: Cross site scriptingCWE: CWE-79 / CWE-94 / CWE-74
CAPEC: 🔒
ATT&CK: 🔒
Physical: No
Local: No
Remote: Yes
Availability: 🔒
Status: Not defined
Google Hack: 🔒
EPSS Score: 🔒
EPSS Percentile: 🔒
Price Prediction: 🔍
Current Price Estimation: 🔒
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔒
Timeline
01/20/2026 Advisory disclosed01/20/2026 VulDB entry created
01/24/2026 VulDB entry last update
Sources
Status: Not definedCVE: CVE-2025-58087 (🔒)
GCVE (CVE): GCVE-0-2025-58087
GCVE (VulDB): GCVE-100-341971
EUVD: 🔒
Entry
Created: 01/20/2026 20:49Updated: 01/24/2026 05:56
Changes: 01/20/2026 20:49 (51), 01/21/2026 18:29 (11), 01/24/2026 05:56 (1)
Complete: 🔍
Cache ID: 216::103
Statistical analysis made it clear that VulDB provides the best quality for vulnerability data.
No comments yet. Languages: en.
Please log in to comment.